TVARDI THERAPEUTICS, INC. Inventory, Work in Process, Gross
TVARDI THERAPEUTICS, INC. (TVRD) had Inventory, Work in Process, Gross of $291.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2025-05-13
- 2025-03-31: Inventory, Work in Process, Gross $291.00K.
- 2024-12-31: Inventory, Work in Process, Gross $291.00K.
- 2024-09-30: Inventory, Work in Process, Gross $16.00K.
- 2024-06-30: Inventory, Work in Process, Gross $1.01M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2025-03-31 | $291.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $291.00K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $16.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.01M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $644.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $708.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $607.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $863.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $499.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $2.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $639.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $812.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.66M 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |